BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25177566)

  • 1. Donor deferral characteristics for plateletpheresis at a tertiary care center in India- a retrospective analysis.
    Pujani M; Jyotsna PL; Bahadur S; Pahuja S; Pathak C; Jain M
    J Clin Diagn Res; 2014 Jul; 8(7):FC01-3. PubMed ID: 25177566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
    Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
    Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
    Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
    J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plateletpheresis donor deferral pattern: A retrospective 4-year data analysis at tertiary care center in India.
    Yadav BK; Shrivastava H; Katharia R; Chaudhary RK
    Asian J Transfus Sci; 2022; 16(2):214-218. PubMed ID: 36687534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and causes of pre-donation deferrals among potential plateletpheresis donors at a blood center in Eastern China.
    Zhu H; Wang J; Lin H
    Transfus Clin Biol; 2023 May; 30(2):189-194. PubMed ID: 36257581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Blood Donor Deferral Rate and the Reasons for Deferral at a Tertiary Care Teaching Institute in Northeastern Malaysia.
    Zahidin MA; Saidin NIS; Ibrahim NA; Mohd Nasir NNA; Abdul Razak NI; Ramli M; Hassan MN; Mohd Noor NH
    Cureus; 2024 Feb; 16(2):e54954. PubMed ID: 38544652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood donor deferral analysis at a center in Western India.
    Agnihotri N
    Asian J Transfus Sci; 2010 Jul; 4(2):116-22. PubMed ID: 20859512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
    Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
    Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Donor Deferral Analysis in Relation to the Screening Process: A Single-Center Study from Southern India with Emphasis on High Hemoglobin Prevalence.
    Kandasamy D; Shastry S; Chenna D; Mohan G
    J Blood Med; 2020; 11():327-334. PubMed ID: 33061730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of reasons of blood donor deferral at a tertiary care institute in India and its reflections on community health status.
    Malhotra S; Negi G
    Asian J Transfus Sci; 2023; 17(1):48-52. PubMed ID: 37188024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plateletpheresis donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India.
    Ojha S; Gupta AM; Nagaraju P; Poojary M; Ravatale A
    Transfus Clin Biol; 2022 Feb; 29(1):65-69. PubMed ID: 34302952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons.
    Al Shaer L; Sharma R; AbdulRahman M
    J Blood Med; 2017; 8():55-60. PubMed ID: 28579846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and causes of pre-donation deferrals at a Chinese blood center.
    Yang Y
    Transfus Apher Sci; 2021 Aug; 60(4):103153. PubMed ID: 34016553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-donation deferral of blood donors in South Indian set-up: An analysis.
    Sundar P; Sangeetha SK; Seema DM; Marimuthu P; Shivanna N
    Asian J Transfus Sci; 2010 Jul; 4(2):112-5. PubMed ID: 20859511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria.
    Okoroiwu HU; Asemota EA
    BMC Health Serv Res; 2019 Jul; 19(1):510. PubMed ID: 31331326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India.
    Pandey P; Tiwari AK; Sharma J; Singh MB; Dixit S; Raina V
    Transfus Apher Sci; 2012 Apr; 46(2):163-7. PubMed ID: 22365925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood donor selection and deferral pattern as an important tool for blood safety in a tertiary care hospital.
    Shrivastava M; Shah N; Navaid S; Agarwal K; Sharma G
    Asian J Transfus Sci; 2016; 10(2):122-6. PubMed ID: 27605848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
    Nomani L; Raina TR; Sidhu M
    Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of efforts to maintain safe donor in main donor pool after completion of temporary deferral period.
    Shah R; Tulsiani S; Harimoorthy V; Mathur A; Choudhury N
    Asian J Transfus Sci; 2013 Jan; 7(1):63-7. PubMed ID: 23559769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.